• Home
  • Stocks
  • Glaxosmithkline Pharmaceuticals Fundamental Analysis
  • Glaxosmithkline Pharmaceuticals Fundamental Analysis

Glaxosmithkline Pharmaceuticals fundamental analysis

GLAXO

HealthcareLarge

2603.6

0.00 (0.00%)
Last updated on 17 Feb, 2026 | 15:51 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Glaxosmithkline Pharmaceuticals Fundamentals

P/E Ratio

43.11

P/B Ratio

21.97

Div. Yield

2.08

Sector P/E

64.32

Sector P/B

2.76

Sec. Div. Yield

0.57

Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 43.11, compared to the sector average of 64.32. Its P/B Ratio stands at 21.97, while the sector’s is 2.76. In terms of returns, the stock offers a Dividend Yield of 2.08%, which is than the sector’s 0.57%.

Glaxosmithkline Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.